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　Long-term volume overload causes an enlargement of vessels. This study was 
undertaken to examine the effects of angiotensin II type 1 (AT-1) receptor antagonist 
CV-11974 on the flow-induced vascular remodeling. Our methods involued the use of an 
artcvia-venous shunt made between the left common carotid artery and the external 
jugular vein in 17 rabbits.  Six weeks after the shunt formation, rabbits were randomly 
assigned to 2 groups: CV-11974 (CV) and saline groups.  Two groups were administered 
CV or saline for 6 weeks.  Sham-operated rabbits were given saline and used as control. 
The results showed a relationship between the cube of luminal diameter and flow was 
linear in CV and saline groups, and this relationship was steeper in CV than in saline 
group.  In isolated carotid arteries, isometric tension produced by angiotensin II was 
significantly augmented at the shunt side in saline group, and this was attenuated to 8% 
and 7%, respectively, after CV in arteries of shunt and contralateral sites.  Derangement 
of acetylcholine-induced endothelium dependent relaxation was noted at the shunt side 
as compared with the contralateral vessels, which was partially reverted to the level of 
sham by CV administration, our conclusions were that vascular remodeling, 
hypercontractile response to angiotensin II and reduced endothelium-dependent 
relaxation in chronic volume overload vessels were improved following a long-term 
administration of AT-1 antagonist.
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INTRODUCTION
　Vessel diameter enlarges structurally in 
response to a long-term increase in blood flow. 
Increases in flow augment the tangential 
component of hemodynamic forces or shear 
stress.1)  Acute dilation of the vessel during 
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abrupt increases in flow such as reactive 
hyperemia is reversible and is explained by 
activation of ion channels2) and G proteins,3) 
and by nitric oxide released from the vascular 
endothelium4)-6). Shear stress also induces 
endothelial nitric oxide synthase (eNOS) 
mRNA expression in a reversible and 
frequency-dependent fashion7),8). A long-term 
increase in blood flow after the shunt 
formation accompanies irreversible structural 
changes across the vessel wall including 
endothelial cell proliferation, an adaptive 
remodeling of the intima and enlargement of 
lumen diameter9),10). A direct relation of the 
magnitude of vessel remodeling to flow 
elevation is also demonstrated in rat mesen-
teric vasculature11). Despite intensive studies 
on the effects of fluid shear stress in vitro on 
endothelial cells, the detailed mechanisms that 
convert the mechanical stimuli to remodeling 
in vivo are not completely understood.
　Angiotensin II is a multifunctional hormone 
that affects both contraction and growth of 
vascular smooth muscle cells12). It also induces 
oxidant stress - dependent hypertrophy of 
cultured vascular smooth muscle cells13). In 
vascular smooth muscle cells, most of the 
angiotensin II effects are mediated by 
angiotensin II type 1 receptor (AT1)14),15). 
Attenuation of hypertrophy by AT1 receptor 
antagonists or angiotensin converting enzyme 
inhibition has been shown mostly in 
hearts,16)-18) in vascular systems with L-NAME 
administration, and in intimal injury, but not 
in vessels under the high flow state19),20). The 
aim of the present study was to elucidate 
whether vascular remodeling was amenable by 
AT-1 receptor antagonist, CV-11974 in a rabbit 
volume-overload model.
METHODS
Animal preparation
　Japanese White male rabbits (Kumagai Sho-
ten, Saitama, Japan) weighing 2.3 to 2.8 kg 
were used.  The rabbits were kept in individual 
cages in an environmentally controlled facility 
at 25℃ and 50 to 60% humidity with light-on 
6:00 AM to 6:00 PM and were fed an ordinary 
stock diet (Labo-R-Grower, Nihon Nosan 
Kogyo, Ltd, Tokyo, Japan) of 120g a day with 
tap water provided ad libitum. The investiga-
tion was conducted with the committee on 
animals of Yamagata University and con-
formed with the Guide for the Care and Use of 
Laboratory Animals published by the US 
National Institutes of Health (NIH publication 
No. 85-23, revised 1996).
Arterio-venous shunt formation
　The rabbits were anesthetized with a bolus 
intravenous administration of sodium pento-
barbital (20mg/kg). Under intratracheal intu-
bation and controlled respiration using a 
positive pressure respirator (Model SN-480-5, 
Shinano Seisakusho, Tokyo, Japan), the left 
common carotid artery and the external 
jugular vein were excised longitudinally 7 mm 
in length and sutured side by side continuously 
with single 8-0 nylon (Kono Seisakusho Co., 
Ltd., Tokyo, Japan), using sterile surgical 
technique in 17 rabbits. Measurements of 
carotid artery flows were undertaken at the 
right and left common carotid arteries 
immediately after the shunt formation using 
an electromagnetic flow probe (Nihon Kohden 
Co., Tokyo, Japan). The common carotid artery 
flow through the anastomosis was about 5 
times of the contralateral arterial flow.  In nine 
rabbits with sham group, vessels were exposed, 
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the incision was closed in layers and the 
animals were allowed to recover.
Long-term drug administration
　Nine sham rabbits were followed for 12 
weeks without medication after the operation. 
Seventeen rabbits with shunt were randomly 
assigned to AT1 receptor antagonist, CV-11974 
(an active metabolite of TCV-116, Takeda 
Chemical Industries, Ltd., Japan, n=8), or 
saline (0.12 ml/day, n=9) administration. 
Osmotic mini pumps (model 2ML2, Alza Co., 
Palo Alto, CA) were implanted subcutaneously 
6 weeks after the shunt operation. These 
capsules of osmotic mini pumps were replaced 
every two weeks until the end of 12 weeks. 
Estimated dose of subcutaneous 
administration was 1 mg/kg/day in CV-11974.
Hemodynamic studies
　Twelve weeks after the shunt formation, the 
rabbits were anesthetized by an intravenous 
administration of sodium pentoba-rbital. A 3F 
Millar catheter (Millar Instruments Inc., 
SPC330, TX) was inserted from the femoral 
artery and the tip was placed at the descending 
aorta. Carotid arterial flow was measured by 
an electromagnetic flow probe (MFV-3200, 
Nihon kohden, Tokyo, Japan).  The pressure 
and flow were recorded on a computerized 
system (Maclab; Analog Digital Instruments 
Pty Ltd., Sydney, Australia)21).
Organ chamber experiments
　After the end of in vivo measurements, the 
rabbits were killed by exsanguination. The 
carotid arteries were removed and immediately 
transported into ice-cold Krebs' bicarbonate 
solution (composition in mmol/L: NaCl 118.4, 
KCl 4.7, CaCl2 2.5, KH2PO4 1.2, MgSO4 1.2, 
NaHCO3 25 and Glucose 11).  The vessel strips 
were cleaned of adhering connective tissues 
and cut into ring segments (2.0 mm in length). 
　To examine the functional state of medial 
smooth muscles, the luminal surface of the 
arterial rings was rubbed with a small wooden 
stick to remove endothelium. Endothelial 
removal was confirmed by an inability of 
relaxation in response to 10-6 M acetylcholine22). 
 Each ring was placed in organ chambers filled 
with 10 ml of Krebs' solution (37℃) bubbled 
with 95% O2/5% CO2 and was attached to a 
force displacement transducer (T7-15-240, 
Orientec Co, Tokyo, Japan). Isometric tension 
was recorded on a polygraph (RJ1000, San-ei, 
Tokyo, Japan). The rings were equilibrated 
under a resting tension of 1 g for 60-90 
minutes, and the buffer was changed every 15 
minutes. Vessels were exposed repeatedly to 60 
mM KCl until a stable maximal contractile 
response was obtained.  
　To evaluate the long-term administration of 
CV-11974, the effect of angiotensin II in a 
concentration of 10-7 M was examined on 
isometric tension measurements in arterial 
rings from sham, shunt + saline, and shunt + 
CV-11974 groups. Due to its tachyphylaxis, 
angiotensin II was not able to add cumulative 
manner. The contractile responses were 
examined in parallel on arterial rings of both 
shunt and contralateral segments, in the 
respective 3 groups. Concentration-dependent 
contractions by phenylephrine were examined.
　The  endothelium-dependent  relaxation 
(EDR) was assessed by acetylcholine-induced 
relaxation of the pre-contracted non-denuded 
arterial rings23).  Acetylcholine was cumula-
tively added. The effects of long-term 
administration of CV-11974 on the endothelial 
function were examined on isolated vessels by 
comparing EDR of arterial rings between 
saline and CV groups. The amplitude of 
relaxation was expressed as % relaxation of the 
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contraction produced by 3×10-6 M pheny-
lephrine. The ED50 was defined as the 
concentration of phenylephrine at which 50% 
of the maximum contraction or relaxation was 
obtained.
Histology and morphometry
　Carotid arteries were excised from shunt 
(shunt and contralateral sides) and sham-
operated rabbits and stored in a 10% buffered 
formaldehyde solution.  
　For morphometric studies, samples were 
embedded in paraffin. Cross sections perpen-
dicular to the blood stream were cut at 3 μm 
intervals, stained with hematoxylin-eosin and 
elastica-Goldner stains.  The sizes of luminal 
diameter were calculated on the traced data 
using an image analyzer.
Statistical analysis
　Data are presented as mean ± SE. 
 Significant difference of mean values between 
two groups was estimated by Student's t-test. 
For multiple comparison, data were analyzed 
by an analysis of variance (ANOVA) followed 
by Sheffe's test.  Correlation between flow and 
the cube of diameter was performed by simple 
linear regression analysis (Statview 4.53, 
Abacus Concepts).  Values of P<0.05 were 
considered to be statistically significant.
　Table 1．Hemodynamics and morphometry of carotid artery
shuntsham
CV-11974salinecharacteristics
3.3±0.1
8
　  100±7*†  
36±7 
147±23 
78±15
512±37 
6
 0.22±0.02*
 0.61±0.04*
0.68±0.13
26.3±3.8 
　0.19±0.02†
　 1.06±0.10*†
　 1.55±0.13*†
　　 69.7±5.1*†§ 
3.3±0.1
9
115±4  
31±6 
143±23 
69±8 
602±76 
6
 0.22±0.01*
 0.60±0.04*
0.62±0.25
24.2±3.9 
　0.18±0.02†
　  1.11±0.10*†
　  1.85±0.75*†
　  50.2±2.2*† 
3.2±0.1
9
113±5
28±5
28±5
28±5
28±5
6
0.18±0.02
0.43±0.04
0.60±0.01
21.7±2.7 
Body weight(kg)
Hemodynamics
　n
　Aortic pressure(mmHg)
　Carotid artely flow(ml/min)
　　immediately after
　　　　　　　contralateral
　　　　　　　shunt
　　12 weeks after contralateral
　　　　　　　shunt
Marphametry
　n
　Contralateral side
　　medial thickness(mm)
　　cross-sectional area of media(mm2)
　　luminal diameter(mm)
　　shear stress(dynes/cm2)
　Shunt side
　　medial thickness(mm)
　　cross-sectional area of media(mm2)
　　luminal diameter(mm)
　　shear stress(dynes/cm2)
Values are mean±SE. 
*p<0.01 versus sham# †p<0.01 between contralateral and shunt
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RESULTS
Hemodynamics 
　Hemodynamic results at 12 weeks after the 
carotid arterio-venous shunt formation and 
sham operation are summarized in Table 1. 
The carotid arterial flows increased by 2.5 to 
2.8 fold at the contra-lateral side and by 18.3 to 
21.5 fold at the shunt side. There was no 
significant difference in flow levels at the 
contra-lateral or shunt side between saline and 
CV groups.  Aortic pressure was significantly 
lower in rabbits of CV group than in those of 
saline or sham group.
　Arterial lumen sizes were measured on 
histological specimens and data are summa-
rized  in  Table1.   There  were  significant 
increases in both medial cross sectional area 
(P<0.01) and luminal diameter (P<0.01) at 
the shunt side (Table 1).  
　The levels of shear stress at 12 weeks after 
the shunt formation were 1.97 (p<0.01) and 
1.12 (NS) fold higher at the shunt and 
contralateral sides than those of sham rabbits, 
respectively.  There was a tendency that the 
luminal diameter is higher as the blood flow 
increases (Fig. 1).  There was a highly linear 
relationship between carotid flow and the cube 
of luminal diameter in both saline and CV 
groups (r=0.98, P<0.01). Since the physical 
equation for shear stress (τ) (τ=4μ・ flow 
volume /π・diamter3) passes the crossing point 
of X and Y axes, slopes of the relationship 
between flow and the cube of diameter are 
comparable between saline and CV groups.  As 
shown in Fig. 1, the slope of the linear 
equation in CV group was larger than saline 
group (P<0.01).
　Fig. 1. 
Plots of the relationship between the cube of 
diameter (mm3) and carotid arterial flow (ml/min),
　shunt and contralateral side (n=6, 
respectively).  The slope represents the level of 
shear stress (dyn/cm2).
　Fig. 2．
Contractile responses to angiotensin II (10-7M) of 
sham, shunt + saline, shunt + CV group. 
Angiotensin II-induced contraction, normalized 
as %contraction of 60mM KCl, was significantly 
larger at the shunt side than the contralateral 
side or the carotid arteries from sham rabbits. 
Angiotensin II-induced contraction was signifi-
cantly attenuated at the shunt as well as 
contralateral side samples after CV-11974 
administration compared with arteries from the 
saline groups.
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Isometric tension studies in vitro
　Contractile responses to a single dose of 
angiotensin   II   (10-7 M)    are   summarized   in
Fig. 2. In saline group, developed tension of the 
vascular rings taken from the shunt side was 
significantly larger than those of the contralat-
eral side (95±3% vs. 56±5% of 60 mM KCl 
contraction in shunt and contralateral arteries, 
respectively, P < 0.01). The concentration-
response relation for phenylephrine of the 
shunt and the contralateral carotid arteries 
were also examined. The concentration-contrac-
tion curves for the shunt side were shifted to 
the left as shown in Fig.3. CV-11974 markedly 
attenuated an-giotensin II-induced tension 
development to 8 ± 2% and to 7 ± 2% of 60 
mM KCl tension in shunt and contralateral 
sides, respectively (P<0.01), as shown in Fig. 2. 
 However, angiotensin II receptor blockade 
with CV-11974 did not affect contraction 
responses to phenylephrine (Fig. 3 and Table 
2).
　Under tonic contractions produced by 
phenylephrine (3×10-6 M), acetylcholine relax-
ed both the shunt and the contralateral 
arterial segments in a concentration dependent 
manner (Fig. 4). The concentration-response 
curve of the shunt side arteries shifted upward 
compared to the contralateral arteries in either 
saline or CV group.  CV-11974 improved the 
relaxing properties of shunt, but not contralat-
eral side vessels, as shown in Fig. 4.  Statistical 
significance was noted in the maximal 
relaxation (60±1% and 68±3%, P<0.01) and 
of ED50 (4.9 ± 0.4 and 2.8 ± 0.6×10-8 M, 
P<0.01) on the shunt side (Table 2).
DISCUSSION
　Arterial wall remodels as a consequence of 
long-term alterations in flow.  Coordination of 
arterial remodeling with the physiological 
　Fig. 3．
Concentration-response curves to phenylephrine 
in vessel arteries isolated from shunt side artery 
and contralateral side artery.
†P< 0.01 between contralateral and shunt
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　Fig. 4．
Concentration-relaxation curves to ace-tylcholine 
in the vessel precontracted with phenylephrine (3
×10-6 M). Relaxing responses of the shunt side 
vessels were attenuated at the peak level and 
ED50 and were recovered partially after CV-
11974. However, this effect on contralateral 
vessels was not discernible.
†P<0.01 between contralateral and shunt
§P<0.01 versus shunt saline
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demand and with the presence of endothelial 
cells has been well documented. Experimental 
manipulation of blood pressure modulates the 
growth of the arterial media24) and that of flow 
rate modulates the size of the luminal 
diameter25), 26). As a direct linear relation 
between the level of flow and the cube of 
diameter of carotid arteries was accomplished 
without changes in medial wall thickness, this 
phenomenon corresponds well with the 
characteristics of vascular remodeling facing 
the volume overload25), 26).  Then, the effects of 
AT-1 receptor antagonist on remodeling was 
studied on physical property of the vessel.  On 
this framework of flow-diameter relation, we 
firstly demonstrated the benefits of long-term 
administration of CV-11974 on remodeling 
induced by volume overload.
　Changes in shear stress alter the production 
of vasoactive substances including growth-
promoting peptides from the endothelial 
cells27), 28), but not from the medial smooth 
muscle cells, except in the injury model20), 29). 
Nitric oxide released from the vascular 
endothelium relaxes promptly the medial 
smooth muscle6) and its sustained release may 
inhibit the proliferation of smooth muscle 
cells30).  In addition to nitric oxide, endothelial 
cells also provide a local source of vasoactive 
agents, including acetylcholine, substance P, 
ATP, serotonin, angiotensin II, vascular 
endothelial growth factor (VEGF) and vaso-
pressin29), 31), 32).  Roberts and Palade have shown 
that VEGF induces fenestrations in hitherto 
nonfenestrated endothelial cells33).
　Diameter enlargement may be due to the 
parallel changes in circumference of the elastic 
laminae that is shown to accompany the 
formation and enlargement of fenestrae over 
the internal elastic lamina without changes in 
numbers of lamellar units34)-36). These micro-
scopical alterations should reduce a barrier for 
humoral and gaseous factors to penetrate from 
the vascular lumen or the intima toward the 
media36).  Then, ensuing activation of signal 
transduction pathways of the medial smooth 
　Table 2．Effects of CV-11974 on relaxation and contraction of vascular rings.
shuntsham
CV-11974saline
117±5* 
146±3†
1.5±0.2
1.0±0.1
131±4  
153±2†
1.8±0.2
　0.8±0.1†
145±5  
1.3±0.2
Max response to phenylephrine
(% of KCl)　　contralateral
         　　shunt
ED50
(10-6 M)　　　contralateral
         　　shunt
85±2 
　　68±3†*§
1.5±0.4
　2.8±0.6§
84±1 
　 60±1†* 
1.8±0.1
　 4.9±0.4†*
82±1 
1.5±0.4
Max response to Acetylcholine
(%)　　　　　contralateral
         　　shunt
ED50
(10-8 M)　　　contralateral
         　　shunt
Values are mean±SE.
†p<0.01 between contralateral and shunt  *p<0.01 versus sham  §p<0.01 versus shunt saline group.
Vascular Remodeling and AT1 Antagonist
－36－
muscle cells may result in the macroscopic and 
functional alterations of the vessel. In the 
present study, the ring preparation from the 
shunt side produced larger tension develop-
ment in response to angiotensin II than the 
contralateral segment. Since the endothelial 
lining was removed, these data suggest the 
increased number of AT1 receptors37) and/or 
the enhanced intracellular signaling in medial 
smooth muscles following chronic influence of 
increased shear stress38).
　Clinical trials and experimental studies have 
demonstrated beneficial effects of ACE 
inhibitors or AT1 receptor antagonists on heart
 failure and left ventricular dysfunction39)-44).  
Although the effects of these agents have also 
been examined experimentally in volume 
overload cardiac hypertrophy17), 18), long-term 
effects of AT1 receptor antagonists on vascular 
remodeling and function have not been 
rigorously examined. The present study showed 
that CV-11974 increased the slope of the 
relation between the level of flow rate and the 
cube of diameter of carotid arteries.  Thus, the 
effect of CV-11974 on vascular remodeling was 
quantified with shear stress as physical 
property and was beneficial for both attenuat-
ing the remodeling and ameliorating the 
vascular function.
　Attenuated contractile responses of the 
vessels to angiotensin II in CV group 
confirmed the effectiveness of the present 
route of drug administration and the tight 
coupling of CV-11974 to AT-1 receptors.  The 
latter finding is in accord well with the 
receptor-binding study45).  A long-term burden 
with volume - overload induces significant 
increases in plasma renin activity, endothelin 
and catecholamines17), 29). Phenylephrine, angio-
tensin II and endothelin are receptor agonists 
that are coupled to Gq protein.  These humoral 
mediators have been postulated to play a role 
in the regulation of cardiac and smooth muscle 
cell growth. In the present study, the 
contractile effects of phenylephrine were not 
modified by CV-11974.  Thus, the effect of CV-
11974 on the angiotensin II induced contrac-
tion is selective and specific.
　In summary, flow-induced diameter increase 
was attenuated by CV-11974 on the framework 
of the flow-cube of diameter relationship.  The 
vascular ring experiments with the absence 
and the presence of endothelial cell lining 
clearly showed enhanced responsiveness to 
angiotensin II and reduced relaxation to 
acetylcholine at the shunt side, respectively.  
The former was totally inhibited and the latter 
was partially ameliorated by a long-term 
treatment with CV-11974.  Thus, this study 
provides the first evidence that a long-term 
administration of AT1 receptor antagonist not 
only attenuates shear stress mediated struc-
tural changes, but also improves functional 
derangements of endothelial and medial 
smooth muscle cells.
　The authors also thank Takeda Chemical 
Industries (Osaka, Japan) for the generous 
supply of CV-11974.
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